Medline Inc. SG&A Expense 2023-2026 | MDLN
Beta
What is sg&a expense?
Selling, general, and administrative expenses include all non-production costs such as marketing, corporate overhead, and management salaries.
What is Medline Inc.'s current sg&a expense?
Medline Inc. (MDLN) annual sg&a expense for 2025 was $4.52B, a 10.13% increase from 2024. Medline Inc. sg&a expense for the quarter ending March 28, 2026 was $1.23B.
What was Medline Inc.'s sg&a expense in 2024?
Medline Inc. annual sg&a expense for 2024 was $4.11B, a 6.23% increase from 2023.
What was Medline Inc.'s sg&a expense in 2023?
Medline Inc. annual sg&a expense for 2023 was $3.87B.
What is Medline Inc.'s 2-year sg&a expense CAGR?
Medline Inc. sg&a expense grew at a compound annual growth rate (CAGR) of 8.16% from FY2023 to FY2025, going from $3.87B to $4.52B over 2 years.
SG&A Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+8.2%
FY2023
$3.87B
→
FY2025
$4.52B
232425
2 years selected
SG&A Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.52B | +10.1% | 10-K |
| FY2024 | $4.11B | +6.2% | 10-K |
| FY2023 | $3.87B | - | 10-K |